Department of Anesthesia and Intensive Care Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.
Reg Anesth Pain Med. 2010 Nov-Dec;35(6):490-5. doi: 10.1097/AAP.0b013e3181ef4d05.
Breast cancer is the most common malignancy in women. Surgery remains the most effective treatment. Several perioperative factors, including the surgical stress response, many anesthetics and opioids, adversely affect immune function. Regional anesthesia-analgesia attenuates perioperative immunosuppression. We tested the hypothesis that patients who receive combined propofol/paravertebral anesthesia-analgesia (propofol/paravertebral) exhibited reduced levels of protumorigenic cytokines and matrix metalloproteinases (MMPs) and elevated levels of antitumorigenic cytokines compared with patients receiving sevoflurane anesthesia with opioid analgesia (sevoflurane/opioid).
Primary breast cancer surgery patients were randomized to propofol/paravertebral (n = 15) or sevoflurane/opioid (n = 17) and preoperative and postoperative serum concentrations of 11 cytokines (interleukin 1β [IL-1β], IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-13, interferon γ, and tumor necrosis factor α) and 3 MMPs (MMP-1, MMP-3, and MMP-9) were measured.
Treatment groups were well balanced for age, weight, surgical procedure, and cancer pathologic diagnosis. Pain scores were lower at 1 and 2 hrs with paravertebral analgesia compared with morphine but similar at 24 hrs. Patients in the propofol/paravertebral group showed a greater percentage decrease in postoperative compared with preoperative IL-1β (median [quartiles], -26% [-15% to -52%] versus -4% [-14% to 2%], P = 0.003), a significant attenuation in elevated MMP-3 (2% [-39% to 12%] versus 29% [23%-59%], P = 0.011) and MMP-9 (26% [13%-54%] versus 74% [50%-108%], P = 0.02), and a significant increase in IL-10 (10% [5%-33%] versus -15% [20% to -2%], P = 0.001) compared with sevoflurane/opioid group. No significantly different changes in IL-2, IL-4, IL-5, IL-6, IL-8, IL-12p70, IL-13, interferon γ, tumor necrosis factor α, or MMP-1 were observed between the 2 groups.
Propofol/paravertebral anesthesia-analgesia for breast cancer surgery alters a minority of cytokines influential in regulating perioperative cancer immunity. Further evaluation is required to determine the significance of these observations.
乳腺癌是女性最常见的恶性肿瘤。手术仍然是最有效的治疗方法。一些围手术期因素,包括手术应激反应、许多麻醉药和阿片类药物,会对免疫功能产生不利影响。区域麻醉-镇痛可减轻围手术期的免疫抑制。我们假设与接受七氟醚麻醉加阿片类药物镇痛(七氟醚/阿片类药物)的患者相比,接受异丙酚/椎旁麻醉-镇痛(异丙酚/椎旁)的患者体内促肿瘤细胞因子和基质金属蛋白酶(MMPs)水平降低,抗肿瘤细胞因子水平升高。
将原发性乳腺癌手术患者随机分为异丙酚/椎旁(n=15)或七氟醚/阿片类药物(n=17)组,术前和术后分别测量血清中 11 种细胞因子(白细胞介素 1β[IL-1β]、IL-2、IL-4、IL-5、IL-6、IL-8、IL-10、IL-12p70、IL-13、干扰素γ和肿瘤坏死因子α)和 3 种 MMPs(MMP-1、MMP-3 和 MMP-9)的浓度。
两组在年龄、体重、手术程序和癌症病理诊断方面均平衡。与吗啡相比,椎旁镇痛在 1 小时和 2 小时时的疼痛评分较低,但在 24 小时时相似。与七氟醚/阿片类药物组相比,异丙酚/椎旁组患者术后 IL-1β(中位数[四分位距],-26%[-15%至-52%]与-4%[-14%至 2%],P=0.003)、升高的 MMP-3(2%[-39%至 12%]与 29%[23%至 59%],P=0.011)和 MMP-9(26%[13%至 54%]与 74%[50%至 108%],P=0.02)百分比下降更大,IL-10(10%[5%至 33%]与-15%[-20%至-2%],P=0.001)百分比增加更大。两组之间 IL-2、IL-4、IL-5、IL-6、IL-8、IL-12p70、IL-13、干扰素γ、肿瘤坏死因子α或 MMP-1 均无明显变化。
乳腺癌手术异丙酚/椎旁麻醉-镇痛改变了少数对调节围手术期癌症免疫有影响的细胞因子。需要进一步评估这些观察结果的意义。